Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction
- 1 March 1998
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 81 (5), 578-581
- https://doi.org/10.1016/s0002-9149(97)00963-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the bypass angioplasty revascularization investigation (BARI)Journal of Electrocardiology, 1996
- A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1995
- Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.Circulation, 1994
- Prospective comparision of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapyJournal of the American College of Cardiology, 1993
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- The Electrocardiogram in Population StudiesCell Metabolism, 1960